The Role of Laboratory Parameters in the Differentiation of Stroke Cases.
| Autor: | Bildik, Busra, Bulak, Dicle, Eroglu, Burcu Simge, Atis, Seref Emre, Cekmen, Bora |
|---|---|
| Předmět: |
STROKE diagnosis
HEALTH services accessibility CROSS-sectional method STATISTICAL correlation PEARSON correlation (Statistics) PLATELET count T-test (Statistics) RECEIVER operating characteristic curves SEX distribution HOSPITAL care HOSPITAL emergency services RETROSPECTIVE studies DESCRIPTIVE statistics AGE distribution HOSPITAL mortality HEMORRHAGIC stroke MANN Whitney U Test CHI-squared test CLINICAL pathology ISCHEMIC stroke RESEARCH STROKE COMPARATIVE studies DATA analysis software COMORBIDITY BIOMARKERS SENSITIVITY & specificity (Statistics) DISEASE complications |
| Zdroj: | Medical Records; 2024, Vol. 6 Issue 3, p396-400, 5p |
| Abstrakt: | Aim: Globally, stroke is considered as one of the most important causes of mortality and morbidity. The most important steps for the diagnosis of stroke include rapid and focused physical examination followed by determination of the stroke's type. The study was conducted to determine the relationship between laboratory parameters frequently requested in the emergency department and stroke type. Material and Method: The study is a retrospective cross-sectional study. Patients' age, gender, comorbidities, stroke type, hospitalization, in-hospital mortality and laboratory parameters were recorded and compared. p value of <0.05 was considered statistically significant. Results: 251 patients were included in the study. The median age of the patients included in the study was 74 [64-81]. 137 (54.6%) of the patients were women. The most common comorbidity in the patients included in the study was hypertension. Ischemic stroke was seen in 236 (94%) patients and 236 (94%) were hospitalized. the platelet count in the hemorrhagic stroke and ischemic stroke group was 173 (153-204) 109/L and 218 (180-2262) 109/L, respectively. Platelet count in patients in the hemorrhagic stroke group was found to be significantly lower than in the ischemic stroke group (p=0.013). There was no significant difference in white blood cell, lymphocyte, sodium, potassium, C-reactive protein levels between both groups (p=0.318, 0.245, 0.461, 0.202, 0.322; respectively). Conclusion: Platelet count may be used as a biomarker to differentiate between ischemic and hemorrhagic stroke in patients who are examined for stroke. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|